未登录A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
Müller, L; Mauthe, RJ; Riley, CM; Andino, MM; De Antonis, D; Beels, C; DeGeorge, J; De Knaep, AGM; Ellison, D; Fagerland, JA; Frank, R; Fritschel, B; Galloway, S; Harpur, E; Humfrey, CDN; Jacks, AS; Jagota, N; Mackinnon, J; Mohan, G; Ness, DK; O'Donovan, MR; Smith, MD; Vudathala, G; Yotti, L .png)
分享.png)
收藏分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
